CVS Health steered through rising costs in its insurance division to handily beat profit expectations on Wall Street.

Barclays analyst Andrew Mok CFA maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $73.00. The ...

CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings surpassing analysts’ ...

By Nadia Ramlagan Public News Service As opioid settlement money continues to flow into Kentucky, counties are having to make ...

CVS Health Corporation (NYSE:CVS) is a retailer that operates in four segments: health care benefits, health services, ...

CVS Health executives cited tech-enabled home care provider Signify Health and primary care entity Oak Street for helping to generate profit growth in the fourth quarter of 2024.

CVS Health’s chief executive is feeling optimistic about working with the Trump administration. On Wednesday, CVS CEO David Joyner said in an interview that he believes there is strong backing for ...

CVS is trying to turn around its drugstore chain and insurance business. The company spent a smaller percentage of premium ...

Bloomberg News Now is a comprehensive audio report on today's top stories. Listen for the latest news, whenever you want it, covering global business stories around the world.

Key Takeaways The S&P 500 dropped 0.3% on Wednesday, Feb. 12, as hotter-than-expected inflation data in the January CPI ...

Super Micro Computer rises after issuing strong guidance for fiscal 2026, Tesla shares trade higher after falling for five days, and CVS Health reports better-than-expected earnings.

U.S. consumer prices increased in January by the most in nearly a year and a half. The surge offered a cautionary note to Trump's push for tariffs.